The authors present a risk analysis of the impact of various business and operating risks on three facility layout strategies.
Harry Silver
Advertisement
Harry Silver is senior process/facility designer at Harry Silver Designs.
Articles by Harry Silver
A multi-purpose biopharmaceutical manufacturing facility using a matrix of multi-functional cleanrooms can be adapted to efficiently meet the capacity challenges of both supplying clinical trials and launching products.
A matrix of multi-functional cleanrooms can be adapted for launching products.
Advertisement
Latest Updated Articles
Multi-Purpose Biopharmaceutical Manufacturing Facilities Part 1: Product Pipeline ManufacturingPublished: November 29th 2018 | Updated:
Multi-Purpose Biopharmaceutical Manufacturing Facilities Part II: Large-Scale ProductionPublished: November 29th 2018 | Updated:
Comparing Facility Layout Options for Managing Business and Operating RisksPublished: June 1st 2019 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
